Most eligible* commercially insured patients pay as little as $5 for their SYPRINE® prescription

The WD Rx Access program helps make it easier for eligible commercially insured patients who are prescribed SYPRINE® (trientine hydrochloride) to have affordable access to the medication they need by reducing monthly co-payment cost to $5. For patients without commercial insurance, you may be eligible for other resources.

Home Delivery

Home Delivery

Your medication can now be mailed directly to your home through a specialty pharmacy, which offers access to pharmacists, auto-fill prescriptions and direct follow-up with physicians.

Nurse Coaching

WD Rx Access also offers the support of a dedicated registered nurse who can provide one-on-one treatment assistance and share information on managing Wilson’s disease. Your coach can share helpful tips on diet, talking to your doctor and disease management.

To reach a nurse, call the hotline at 1 (888) 878-4153.

Nurse Coach

Enroll Today

All Fields Required

By providing your information above, you are requesting to be contacted about WD Rx Access by Bausch Health. The information you provide will be used by the Bausch Health Companies Inc., our affiliates, and our service providers to satisfy this purpose. The information you provide will be further governed by Bausch Health Companies Inc. Privacy Policy. By providing the information and selecting the SUBMIT button, you indicate that you read, understand, and agree to these terms, and confirm you have read and agree with this Privacy Policy.

*This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan or any other federal or state health care programs. These patients may qualify for alternative financial assistance. These offers are only good for use with SYPRINE®. No other purchase necessary. These offers are not health insurance. These offers are not transferable. These offers are not valid with other offers. These offers have no cash value. The patient understands and agrees to comply with the terms and conditions of these offers. Program term eligibility expires December 31, 2020. Bausch Health reserves the right to rescind, revoke, terminate, or amend these offers at any time, with or without notice. For more information, call a WD Rx Access representative at 888-607-7267.

Frequently Asked Questions

Find out answers to the most frequently asked questions about the WD Rx Access program.

Learn More

Find Support

If you have Wilson’s disease, you are not alone. Check out a list of groups that will help you learn more and find support among other Wilson’s disease patients and their families.

Learn More

 

Indication

SYPRINE® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. SYPRINE® is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis.

Important Safety Information
  • Do not take SYPRINE® if you are allergic to it or any parts of the formulation.
  • You should remain under regular medical supervision the entire time you are taking SYPRINE®. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women.
  • Take SYPRINE® on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor.
  • Tell your doctor if you are pregnant, plan to become pregnant, or are nursing.
  • The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis.
  • Do not take mineral supplements because they may block the absorption of SYPRINE®.

You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information for SYPRINE® Capsules.

Indication
Indication

SYPRINE® (trientine hydrochloride) is used to treat Wilson's disease in patients who cannot take the medication known as penicillamine. Wilson's disease is a condition where the body stores too much copper. SYPRINE® is not recommended to treat cystinuria (a condition where a protein known as cystine is excreted into the urine), rheumatoid arthritis, or a disease affecting the bile ducts in the liver known as biliary cirrhosis.

Important Safety Information
Important Safety Information
  • Do not take SYPRINE® if you are allergic to it or any parts of the formulation.
  • You should remain under regular medical supervision the entire time you are taking SYPRINE®. Your doctor should regularly check to see if you have iron deficiency anemia. This is particularly important for women.
  • Take SYPRINE® on an empty stomach, at least one hour before a meal or two hours after a meal and at least one hour apart from any other drug, food, or milk. The capsules should be swallowed whole with water and should not be opened or chewed. For the first month of treatment, take your temperature every night, and report any symptom such as fever or skin rash to your doctor.
  • Tell your doctor if you are pregnant, plan to become pregnant, or are nursing.
  • The following adverse reactions have been reported from a clinical study: iron deficiency and a condition affecting the immune system known as systemic lupus erythematosus. In addition, the following adverse reactions have been reported in marketed use: abnormal or uncontrolled muscle contractions, muscle spasm and an immune disease affecting muscles known as myasthenia gravis.
  • Do not take mineral supplements because they may block the absorption of SYPRINE®.

You are encouraged to report negative side effects of prescription drugs to FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.

Please click here for full Prescribing Information for SYPRINE® Capsules.